Bial

Jul 10, 2019

Neurocrine Biosciences Announces FDA Acceptance of New Drug Application for Opicapone as an Adjunctive Treatment for Patients with Parkinson's Disease

Nov 20, 2018

BIAL Foundation Launch New Nobel-Style Award in Biomedicine

Nov 05, 2018

Neurocrine Biosciences Reports Third Quarter 2018 Financial Results

Jul 31, 2018

Neurocrine Biosciences Reports Second Quarter 2018 Financial Results

Feb 13, 2018

Neurocrine Biosciences Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Investor Update for 2018

Sep 19, 2017

New Review Entitled Reflections on the Use of Perampanel in Epilepsy - Lessons from the Clinic and Real-world Evidence

Aug 03, 2017

Neurocrine Biosciences Reports Second Quarter 2017 Results

Jun 01, 2017

Reflections on the Use of Perampanel in Epilepsy - Lessons From the Clinic and Real-world Evidence